Partially matched bone marrow transplantation in patients with myelodysplastic syndromes.
Explore this paper's citation graph
Summary
Partially matched T-depleted bone marrow from related or unrelated donors may be effective, and possibly curative therapy for patients with MDS who lack a histocompatibility locus antigen (HLA)-identical sibling donor.
- Type
- article
- Published
- 1988-12-01
- Cited by
- 43
- References
- 0
- OpenAlex
- https://openalex.org/W1943799786
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:41541763
Keywords
Medicine, Busulfan, Total body irradiation, Bone marrow, Gastroenterology
References
No references recorded for this paper.
Cited by
- Intensive chemotherapy and bone marrow transplantation for myelodysplastic syndromes.
- Myelodysplastic syndromes in childhood--classification, epidemiology, and treatment.
- Exocrine pancreatic insufficiency after allogeneic bone marrow transplantation
- Prognosis and therapy of myelodysplastic syndromes.
- Myelodysplastic syndromes: Pathogenesis, diagnosis and treatment
- Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): Report of three cases
- Allogeneic marrow transplantation for myelodysplastic syndrome complicating autologous bone marrow transplantation.
- Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG)
- Bone marrow transplantation for myelodysplasia.
- Allogeneic bone marrow transplantation for myelodysplastic syndromes of childhood: report of three children with refractory anemia with excess of blasts in transformation and review of the literature.
- Myelodysplastic syndromes in childhood: a population based study of nine cases
- Treatment and prognostic factors in myelodysplastic syndromes.
- Second malignancies following treatment in non-Hodgkin's lymphoma.
- The myelodysplastic syndromes: current approaches to therapy.
- Allogeneic hematopoietic cell transplantation from alternative donors in children with myelodysplastic syndrome: is that an alternative?
- Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program.
- Therapy-related myeloid leukemia.
- Bone marrow transplantation in children.
- Arsenic trioxide as a treatment for myelodysplastic syndrome
- Myelodysplastic syndromes: recent advances.
Related papers
- Pulmonary complications of bone marrow transplantation (bmt): a comparison of total body irradiation & cyclophosphamide (TBI-CY) to busulfan & cyclophosphamh)e (BU-CY)
- RECIPIENT PREPARATION FOR BONE MARROW TRANSPLANTATION I. EFFICACY OF TOTAL‐BODY IRRADIATION AND BUSLFAN
- A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group.
- Comparison of busulfan and cyclophosphamide in the treatment of chronic myelocytic leukemia
- Busulfan and total body irradiation as antihematopoietic stem cell agents in the preparation of patients with congenital bone marrow disorders for allogenic bone marrow transplantation
- Pulmonary complications of bone marrow transplantation: a comparison of total body irradiation and cyclophosphamide to busulfan and cyclophosphamide.
- A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group
- Busulfan and total body irradiation as antihematopoietic stem cell agents in the preparation of patients with congenital bone marrow disorders for allogenic bone marrow transplantation.
- Late tissue-specific toxicity of total body irradiation and busulfan in a murine bone marrow transplant model.